erlotinib hydrochloride has been researched along with g(m3) ganglioside in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (g(m3) ganglioside) | Trials (g(m3) ganglioside) | Recent Studies (post-2010) (g(m3) ganglioside) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 1,010 | 17 | 222 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, K; Dalton, S; Dookwah, M; Ishihara, M; Kulik, MJ; Steet, R; Strauss, KA; Tiemeyer, M; Ulrichs, H; Wagner, SK; Yu, SH; Zeltner, N | 1 |
1 other study(ies) available for erlotinib hydrochloride and g(m3) ganglioside
| Article | Year |
|---|---|
Neural-specific alterations in glycosphingolipid biosynthesis and cell signaling associated with two human ganglioside GM3 synthase deficiency variants.
Topics: Erlotinib Hydrochloride; G(M3) Ganglioside; Gangliosides; Glycosphingolipids; Humans; Sialyltransferases; Signal Transduction | 2023 |